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Improving Surveillance of Hepatitis C Infections Among Patients 
Receiving Medication Treatment for Opioid Use Disorder
Background 
§ Abuse of opioids has shifted from oral to injection use, 
resulting in greater risk of infectious disease transmission
§ The number of new Hepatitis C virus (HCV) infections in 
the US has tripled
§ Treating acute infections of HCV vs. managing chronic 
Hepatitis C is expected to result in $12 billion in total 
cumulative savings to Medicaid by 2022 
§ Despite engagement in treatment, individuals with opioid 
use disorder (OUD) remain at risk for contracting and 
transmitting infectious disease, yet many mOUD programs 
screen patients upon admission only. 
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Purpose 
§ Implement a HCV re-screening protocol in a mOUD
program and determine sustainability of protocol 
§ Secondarily, determine if point of care finger stick tests 
would be a preferred modality to use for screening 
Methods 
§ Patients with an unknown or negative HCV antibody 
test result upon admission were offered to complete a 
risk survey 
§ Patients were given a list of risk factors for 
HCV, and asked to answer if they applied 
YES/NO 
§ IF YES, patients were asked if they would 
like be re-screened for HCV 
§ If interested in rescreening, patients were offered an 
onsite venipuncture 
§ Patients who declined rescreening, were asked if they 
would re-consider if the testing modality was a finger 
stick
§ Patients with a positive HCV RNA viral load received a 
referral to UVMMC Infectious Disease 
§ Nursing staff, medical providers, and administrative 
leaders provided feedback via an online survey
Results Discussion 
§ A brief questionnaire administered to patients regarding 
risk factors for HCV can help facilitate targeted 
screening efforts 
§ Uptake of re-screening may improve if less invasive 
screening modalities were used 
§ Nursing staff agreed that re-screening surveys were 
easy to implement, and introduced opportunities to talk 
with patients about their risk factors for contracting 
HCV, and review the importance of routine screening 
§ Stakeholders agreed that routine surveillance of HCV is 
important, and fits within the the scope of practice of 
mOUD treatment 
Implications for Future Practice 
§ Risk questionnaires could be distributed to patients 
receiving medication for OUD in primary care settings 
§ Surveillance services offered in mOUD treatment 
programs may qualify for enhanced-rate reimbursement 
§ In addition to on-site identification of HCV, treatment of 
HCV in a mOUD setting is cost effective and patient 
centered
Survey Questions 
1. The risk survey was easy to administer to patients. 
2. Administering the risk survey at the dosing window did not interrupt 
work flow. 
3. Administering the risk survey at the dosing window did not interfere 
with responsibilities of the dosing nurse. 
4. Entering and updating flags in the electronic health system to facilitate 
surveillance of HCV is feasible to add to nursing work flow. 
5. I am comfortable performing venipuncture on patients who wish to be 
re-screened at the clinic.
6. I would be comfortable performing a finger stick at the dosing window 
to collect a sample of blood to re-screen patients for HCV if proper 
training were provided. 
7. Having patients complete the risk survey at the window presents a brief 
opportunity to educate patients about the risk factors for Hepatitis C 
and the importance of routine screening. 
8. Dispensing HCV medication with a patient’s daily dose is easy and is 
an effective strategy to promote medication adherence. 
Survey Questions 
1. It is important to re-screen patients who had a negative HCV antibody result 
upon admission to the Chittenden Clinic. 
2. It is important to offer re-screening for HCV antibody to patients at the 
Chittenden Clinic 6 months after the initial negative result. 
3. It is important to offer re-screening for HCV antibody to patients at the 
Chittenden Clinic 1 year after the initial negative result. 
4. It is within the Chittenden Clinic’s scope of practice and treatment program 
to offer health care services such as screening, diagnosing, and care 
coordination for patients at risk for and/or who have an infectious disease. 
5. Re-screening for infectious disease, is the responsibility of the patient’s 
primary care provider or public health service team, and not the 
responsibility of the Chittenden Clinic.  
6. Point of care testing for HCV is a service that should be offered to patients at 
the Chittenden Clinic. 
7. It is important for Chittenden Clinic providers to be able to prescribe 
medications to treat Hepatitis C. 
8. The Chittenden Clinic offers a unique environment in which the 
identification and treatment of Hepatitis C can be can managed effectively.  
9. It is the role and responsibility of the Chittenden Clinic care team to educate 
patients on the risk of contracting Hepatitis C.
10. The Chittenden Clinic should prioritize improving the surveillance of 
infectious disease among its patients. 
Conclusion 
§ Integration of HCV surveillance services at mOUD
treatment programs provides a sustainable approach to 
reduce the public health burden of infectious disease 
